Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Yoshiaki, Tsuka"'
Autor:
Ohki Hayashi, Seishi Nakamura, Tetsuro Sugiura, Shun Hasegawa, Yoshiaki Tsuka, Nobuyuki Takahashi, Sanae Kikuchi, Koichiro Matsumura, Toshika Okumiya, Masato Baden, Ichiro Shiojima
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-9 (2023)
Abstract Background The improvement of anaemia over time by erythropoiesis stimulating agent (ESA) is associated with better survival in haemodialysis patients. We previously reported that erythrocyte creatine content, a marker of erythropoietic capa
Externí odkaz:
https://doaj.org/article/6feceb4db1534476b48b69f9c048d595
Autor:
Shun Hasegawa, Seishi Nakamura, Tetsuro Sugiura, Yoshiaki Tsuka, Nobuyuki Takahashi, Koichiro Matsumura, Toshika Okumiya, Masato Baden, Ichiro Shiojima
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background One of the main causes of anaemia in patients with end-stage renal disease is relative deficiency in erythropoietin production. Eythropoiesis stimulating agent (ESA), a potent haematopoietic growth factor, is used to treat anaemia
Externí odkaz:
https://doaj.org/article/cc95294efc7b419c9aec6a270dde364a
Autor:
Ohki, Hayashi, Seishi, Nakamura, Tetsuro, Sugiura, Shun, Hasegawa, Yoshiaki, Tsuka, Nobuyuki, Takahashi, Sanae, Kikuchi, Koichiro, Matsumura, Toshika, Okumiya, Masato, Baden, Ichiro, Shiojima
Background The improvement of anaemia over time by erythropoiesis stimulating agent (ESA) is associated with better survival in haemodialysis patients. We previously reported that erythrocyte creatine content, a marker of erythropoietic capacity, was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1249ca18382061da45eec4342951ade
https://doi.org/10.21203/rs.3.rs-2183749/v1
https://doi.org/10.21203/rs.3.rs-2183749/v1
Autor:
Koichiro Matsumura, Tetsuro Sugiura, Toshika Okumiya, Seishi Nakamura, Yoshiaki Tsuka, Shun Hasegawa, Nobuyuki Takahashi, Masato Baden, Ichiro Shiojima
Background: One of the main causes of anaemia in patients with end-stage renal disease is relative deficiency in erythropoietin production. Recombinant human erythropoietin (rHuEpo), a potent haematopoietic growth factor, is used to treat anaemia in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::039b1fb03e9f43aedd9312d871013817
https://doi.org/10.21203/rs.3.rs-792979/v1
https://doi.org/10.21203/rs.3.rs-792979/v1
Autor:
Susumu Yoshida, Seishi Nakamura, Toshiji Iwasaka, Hirofumi Maeba, Takeshi Senoo, Tetsuro Sugiura, Yoshiaki Tsuka, Fumio Yuasa, Masato Baden, Kazuya Takehana
Publikováno v:
Annals of Nuclear Medicine. 23:383-390
The amount of myocardial salvage after percutaneous coronary intervention (PCI) is reported to be a major determinant of functional recovery in patients with ST-elevation acute myocardial infarction (MI). However, factors related to the amount of myo
Autor:
Nobuyuki Takahashi, Tetsuro Sugiura, Kengo Hatada, Yoshiaki Tsuka, Yoshiteru Abe, Toshiji Iwasaka
Publikováno v:
Coronary Artery Disease. 10:465-470
BACKGROUND Precordial ST-segment depression in acute inferior infarction is well recognized, but few studies have evaluated ST-segment elevation in lateral precordial leads. The present study examined the clinical significance of ST-segment elevation
Autor:
Masato Baden, Tetsuro Sugiura, Kengo Hatada, Yoshiaki Tsuka, Toshiji Iwasaka, Seishi Nakamura, Yusuke Fujikawa, Shigeo Umemura, Keisuke Fujitaka
Publikováno v:
Nuclear medicine communications. 30(10)
Multislice computed tomography (MSCT) coronary angiography (CAG) is limited in detecting significant coronary artery stenosis because of its low specificity and positive predictive value. Stress-rest myocardial perfusion imaging (MPI) can detect myoc
Autor:
Michio Shimojo, Tetsuro Sugiura, Seishi Nakamura, Yoshiaki Tsuka, Shigeo Umemura, Masato Baden, Toshiji Iwasaka
Publikováno v:
Nuclear medicine communications. 29(11)
OBJECTIVE To investigate the cardioprotective effect of intravenous nicorandil before primary percutaneous coronary intervention (PCI) on preservation of myocardial viability, we studied 199 consecutive patients with acute myocardial infarction. METH
Autor:
Toshiji Iwasaka, Shigeo Umemura, Keisuke Fujitaka, Tetsuro Sugiura, Susumu Yoshida, Yoshiaki Tsuka, Seishi Nakamura, Masato Baden
Publikováno v:
Nuclear medicine communications. 27(3)
OBJECTIVE: Angiographic thrombolysis in myocardial infarction (TIMI) flow grade < or = 2 after primary percutaneous coronary intervention (PCI), defined as angiographic no-reflow, predicts poor functional recovery in patients with acute myocardial in
Autor:
Shigeo, Umemura, Yoshiaki, Tsuka, Seishi, Nakamura, Minako, Tsuka, Tetsuya, Kitamura, Susumu, Yoshida, Tetsuro, Sugiura, Masato, Baden, Toshiji, Iwasaka
Publikováno v:
Journal of cardiology. 45(5)
A 59-year-old man with acute myocardial infarction underwent successful stent implantation for proximal left anterior descending coronary artery occlusion. Antiplatelet therapy with 100 mg aspirin/day and 200 mg cilostazol/day was started after stent